Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia × tafasitamab × 30 days × Clear all

Sponsor

Conditions

Recurrence 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell 1 Lymphoma 1 Hodgkin Disease 1 Burkitt Lymphoma 1

Interventions

venetoclax 10 Cyclophosphamide 7 Azacitidine 6 fludarabine phosphate 5 fludarabine 5 Cytarabine 4 Mycophenolic Acid 3 Mesna 3 Melphalan 3 Decitabine 3 Bone Marrow Transplantation 3 ruxolitinib 2 revumenib 2 quizartinib 2 ponatinib 2 pembrolizumab 2 Whole-Body Irradiation 2 Rituximab 2 Interleukin-2 2 Granulocyte Colony-Stimulating Factor 2 Filgrastim 2 Daunorubicin 2 Busulfan 2 Bendamustine Hydrochloride 2 talazoparib 1 pirtobrutinib 1 pegaspargase 1 obinutuzumab 1 nelarabine 1 ivosidenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡